Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$495M |
| 2 |
ExxonMobil
XOM
|
+$290M |
| 3 |
FedEx
FDX
|
+$273M |
| 4 |
Netflix
NFLX
|
+$262M |
| 5 |
RTX Corp
RTX
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$290M |
| 2 |
EA
Electronic Arts
EA
|
+$280M |
| 3 |
Mastercard
MA
|
+$252M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$245M |
| 5 |
Johnson & Johnson
JNJ
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.71% |
| 2 | Technology | 15.33% |
| 3 | Financials | 11.4% |
| 4 | Industrials | 9.58% |
| 5 | Consumer Staples | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Insperity
NSP
$2.05B
| $30.7M | 0.04% |
696,800
+63,534
| +10% | +$2.52M |
|
652
Weis Markets
WMK
$1.77B
| $30.6M | 0.04% |
704,600
+67,000
| +11% | +$3.04M |
|
|
RIC
653
DELISTED
Richmont Mines Inc.
RIC
| $30.6M | 0.04% |
3,270,800
+99,400
| +3% | +$845K |
|
654
Southside Bancshares
SBSI
$984M
| $30.5M | 0.04% |
839,210
+4,200
| +0.5% | +$143K |
|
655
Hubbell
HUBB
$26.8B
| $30.5M | 0.04% |
262,900
+112,000
| +74% | +$12.8M |
|
|
ILG
656
DELISTED
ILG, Inc Common Stock
ILG
| $30.5M | 0.04% |
1,139,229
+1,067,414
| +1,486% | +$28.2M |
|
657
Regis Corp
RGS
$70.1M
| $30.4M | 0.04% |
106,655
+8,645
| +9% | +$1.99M |
|
|
GXP
658
DELISTED
Great Plains Energy Incorporated
GXP
| $30.3M | 0.04% |
999,815
+603,600
| +152% | +$18.5M |
|
|
SAVE
659
DELISTED
Spirit Airlines, Inc.
SAVE
| $30M | 0.04% |
898,800
+793,700
| +755% | +$31.8M |
|
660
LivePerson
LPSN
$35.9M
| $30M | 0.04% |
147,420
+7,280
| +5% | +$1.4M |
|
661
Loews
L
$23B
| $30M | 0.04% |
625,800
+10,900
| +2% | +$519K |
|
|
SCG
662
DELISTED
Scana
SCG
| $29.9M | 0.04% |
617,600
-580,800
| -48% | -$35.6M |
|
|
BECN
663
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $29.9M | 0.04% |
584,057
+540,900
| +1,253% | +$25.2M |
|
|
TARO
664
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $29.9M | 0.04% |
265,300
-5,466
| -2% | -$595K |
|
665
Ternium
TX
$10.7B
| $29.9M | 0.04% |
965,400
+6,600
| +0.7% | +$200K |
|
666
BioMarin Pharmaceuticals
BMRN
$13.3B
| $29.8M | 0.04% |
320,271
+193,400
| +152% | +$17.1M |
|
667
B2Gold
BTG
$6.7B
| $29.8M | 0.04% |
10,650,497
-50,100
| -0.5% | -$133K |
|
668
ScottsMiracle-Gro
SMG
$3.59B
| $29.8M | 0.04% |
305,700
+48,549
| +19% | +$4.6M |
|
669
Valmont Industries
VMI
$9.5B
| $29.7M | 0.03% |
187,800
-15,900
| -8% | -$2.4M |
|
670
Bio-Techne
TECH
$11.2B
| $29.6M | 0.03% |
978,800
+390,400
| +66% | +$11.6M |
|
671
Baxter International
BAX
$14B
| $29.4M | 0.03% |
468,113
-1,510,300
| -76% | -$93.3M |
|
|
VIVO
672
DELISTED
Meridian Bioscience Inc
VIVO
| $29.3M | 0.03% |
2,051,776
+84,476
| +4% | +$1.21M |
|
673
Forestar Group
FOR
$1.51B
| $29.3M | 0.03% |
1,704,507
-382,996
| -18% | -$6.58M |
|
|
XOXO
674
DELISTED
Xo Group Inc
XOXO
| $29.3M | 0.03% |
1,487,500
+14,200
| +1% | +$261K |
|
|
KBAL
675
DELISTED
Kimball International
KBAL
| $29.2M | 0.03% |
1,474,500
+165,509
| +13% | +$2.82M |
|
Similar funds
Jim Simons's Q3 2017 Portfolio in Review
As of Q3 2017, Jim Simons held 3,587 positions worth $85B, up 8.4% from $78.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Jim Simons deployed $2.91B of net new capital in Q3 2017, opening 418 new positions and adding to 1,684 existing holdings. Its largest new stake was ExxonMobil: 3,652,454 shares worth $299M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Electronic Arts, an estimated $280M trimmed.
- Jim Simons's largest Q3 2017 buy was ExxonMobil: 3,652,454 shares worth $299M.
- Jim Simons added most to Medtronic in Q3 2017, an estimated $495M increase.
- Jim Simons's biggest Q3 2017 reduction was Electronic Arts, cutting an estimated $280M.
- Jim Simons fully exited Amazon in Q3 2017, selling an estimated $290M.
- Jim Simons's ten largest holdings make up 8.5% of its $85B portfolio in Q3 2017.
- Jim Simons opened 418 new positions and closed 418 in Q3 2017.
- Jim Simons's portfolio value rose 8.4% quarter-over-quarter to $85B.
Based on Renaissance Technologies's 13F filing for Q3 2017, filed 13 Nov 2017.